lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2

lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2

Lung cancer (LC) is a prevailing primary tumor in the lung. lncRNA non-coding RNA activated by DNA damage (NORAD) is a popular target in human cancers. This experiment is designed to probe the mechanism of lncRNA in LC progression. NORAD expression in normal lung epithelial cells and LC cells was ex...

Full description

Bibliographic Details
Main Authors: Mao Wenjun, Wang Shengfei, Chen Ruo, He Yijun, Lu Rongguo, Zheng Mingfeng
Format: Article
Language:English
Published: De Gruyter 2022-09-01
Series:Open Medicine
Subjects:
lung cancer
lncrna norad
mir-28-3p
e2f2
competitive endogenous rna cell proliferation
Online Access:https://doi.org/10.1515/med-2022-0538

Similar Items

Similar Items